Refractory Epilepsy: Clinical Trials

3 trials for Refractory Epilepsy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 21Completed 1

Follow Refractory Epilepsy: new trials by email Literature Review of Refractory Epilepsy trials Research Report on Refractory Epilepsy

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Leucine Enriched Essential Amino Acid Powder as an Add-on to a Classic Ketogenic Diet in Refractory Epilepsy
Leucine-Enriched Essential Amino Acid powder - Refractory Epilepsy, Drug Resistant Epilepsy
Phase 1CompletedElizabeth Anne Thiele42024-05-102026-05-22
Intrathecal Autologous ADRC Treatment of Autoimmune Refractory Epilepsy
ADRC transplantation in autoimmune refractory epilepsy - Refractory Epilepsy
Phase 1CompletedMossakowski Medical Research Centre Polish Academy of Sciences62015-11-152020-04-15
Thalidomide Low Threshold in Epilepsy
3-phthalimidoglutarimide (Thalidomide) - Refractory Epilepsy
Phase 1 / Phase 2CompletedNational Institute of Neurology and Neurosurgery, Mexico72006-06-012010-02-18

Narrower conditions

Drug Resistant Epilepsy (3)

Broader conditions

Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Epilepsy (3)  ·  Nervous System Diseases (3)

Interventions

Thalidomide (1)

Sponsors

Elizabeth Anne Thiele (1)  ·  Mossakowski Medical Research Centre Polish Academy of Sciences (1)  ·  National Institute of Neurology and Neurosurgery, Mexico (1)

Countries

United States (1)

Top investigators

Dorota Antczak-Marach, M.D. (1)  ·  Elizabeth Thiele, MD, PhD (1)  ·  Ewa Sawicka, Prof. (1)  ·  Julio Sotelo, MD (1)

Results publications

PMID 32190059